Compound Report Overview
Compound Name:
RAPAMYCIN
Compound Identifier:
700739
Mol Structure 2D:
700739
Molecular Weight:
914
Formula:
C51 H79 N O13
Development Status:
US FDA Approved
SMILES:
COC1CC(CC(C)C2CC(=O)C(C)C=C(C)C(O)C(OC)C(=O)C(C)CC(C)C=CC=CC=C(C)C(CC3CCC(C)C(O)(O3)C(=O)C(=O)N4CCCCC4C(=O)O2)OC)CCC1O
Compound Activites
| Compound | Assay | Assay Name | View |
|---|---|---|---|
| RAPAMYCIN | 638 | Testosterone | View |
| RAPAMYCIN | 639 | Thromboxane Synthetase | View |
| RAPAMYCIN | 619 | Adenosine A3 | View |
| RAPAMYCIN | 125 | Estrogen ERalpha | View |
| RAPAMYCIN | 116 | Dopamine D3 | View |
| RAPAMYCIN | 642 | CYP450-2C9 Inhibition | View |
| RAPAMYCIN | 79 | Adenosine Transporter | View |
| RAPAMYCIN | 644 | CYP450-3A4 Inhibition | View |
| RAPAMYCIN | 641 | CYP450-2C19 Inhibition | View |
| RAPAMYCIN | 695 | Potassium Channel HERG | View |
| RAPAMYCIN | 216 | Sodium Channel, Site 2 | View |
| RAPAMYCIN | 625 | GABAA, Chloride Channel, TBOB | View |
| RAPAMYCIN | 208 | Serotonin 5-HT4 | View |
| RAPAMYCIN | 643 | CYP450-2D6 Inhibition | View |